2 unknown, 1 completed. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Unknown 2, Completed 1 |
Follow Long Covid19: new trials by email Literature Review of Long Covid19 trials Research Report on Long Covid19
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Treatment of Post-COVID-19 With Hyperbaric Oxygen Therapy: a Randomized, Controlled Trial Hyperbaric oxygen - Post-COVID-19 Syndrome, Post-COVID Syndrome | Phase 3 | Unknown | Erasmus Medical Center | 120 | 2024-10-01 | 2024-02-28 |
| IMMUNERECOV CONTRIBUTES TO IMPROVEMENT OF RESPIRATORY AND IMMUNOLOGICAL RESPONSE IN POST-COVID-19 PATIENTS. Nutritional blend (ImmuneRecov). - Long Covid19, Dietary Supplements | Phase 3 | Unknown | Federal University of São Paulo | 58 | 2023-12-10 | 2023-12-12 |
| Effectiveness of Testofen Compared to Placebo on Long COVID Symptoms Testofen, Microcrystalline cellulose - Long Covid19 | Phase 3 | Completed | RDC Clinical Pty Ltd | 150 | 2023-10-25 | 2025-03-10 |
Post-Acute COVID-19 Syndrome (3) · COVID-19 (1) · Inflammation (1) · Respiratory Tract Infections (1)
Chronic Disease (3) · Coronaviridae Infections (3) · Coronavirus Infections (3) · Disease Attributes (3) · Infections (3) · Lung Diseases (3) · Nidovirales Infections (3) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Pneumonia (3) · Pneumonia, Viral (3) · Post-Infectious Disorders (3) · RNA Virus Infections (3) · Respiratory Tract Diseases (3) · Virus Diseases (3)
Hyperbaric Oxygenation (1) · microcrystalline cellulose (1)
Erasmus Medical Center (1) · Federal University of São Paulo (1) · RDC Clinical Pty Ltd (1)
Australia (1) · Brazil (1) · Netherlands (1)
Amanda Rao, PhD (1) · Rodolfo de Paula Vieira, BSc., MSc., PhD. (1)